Cost-effectiveness of 2023-2024 COVID-19 vaccination in US adults

JAMA Network Open

2025-08-07

(Press-News.org) About The Study: In this modeling study, economic favorability of COVID-19 vaccination varied by age. Cost-effectiveness results for individuals in the 2 older age groups were favorable and generally robust to changes in parameter inputs, while results for the younger age group were sensitive to parameter input changes. As the evidence base for COVID-19 vaccination and burden of illness evolves, it may be important to continue to update and revise the economic evaluation of vaccination. The Advisory Committee on Immunization Practices considered these results in its decision to recommend vaccination with the 2023 to 2024 COVID-19 mRNA vaccines.

Corresponding Author: To contact the corresponding author, Lisa A. Prosser, PhD, email lisapros@umich.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2025.23688)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.23688?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080725

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

Demographics, lifestyle, comorbidities, prediabetes, and mortality

2025-08-07

About The Study: Stratified analyses in this study revealed that prediabetes was significantly associated with mortality only among younger adults (ages 20-54), highlighting the importance of age-specific interventions. Lifestyle behaviors, limited health care access, and life stage challenges may contribute to the increased mortality risk in younger adults. Early-onset health problems in this group may also reflect stronger genetic predispositions, leading to more rapid disease progression and more severe health outcomes. These findings underscore ...

Climate change: Perito Moreno Glacier retreat has recently accelerated substantially

2025-08-07

The Perito Moreno Glacier in Argentina — often described as one of the most stable glaciers in Patagonia — is retreating far more rapidly than previously thought, according to a paper in Communications Earth & Environment. The results show that, over the last few years, the glacier has retreated by as much as 800 metres in some areas, and that it may collapse and retreat by several kilometres in the near future. The Perito Moreno Glacier is a 30-kilometre-long glacier in the Argentine Patagonia, fed by the Southern Patagonian Ice Field in the Andes and terminating in ...

Population history of the Southern Caucasus

2025-08-07

To the point Stable genetic ancestry: Despite significant cultural changes, populations in the Southern Caucasus have maintained remarkably constant genetic ancestry for over 5,000 years. Genetic contributions during the Bronze Age: Although local genetic continuity was predominant, there were partial genetic contributions from the Eurasian Steppe and from Anatolia during the Bronze Age. Cultural influences: Practices such as cranial deformation were adopted primarily through cultural influences, rather than solely through migration. New insights into the Southern Caucasus region: This research highlights the Southern Caucasus as ...

Biomarkers reveal risk of cardiovascular disease in type 2 diabetes

2025-08-07

Quick facts: Clinical research, 752 individuals with type 2 diabetes, quantitative study, DNA methylation as a way to identify epigenetic biomarkers in blood. People with type 2 diabetes are up to four times more likely to have heart attacks, strokes, anginas and other coronary heart diseases than healthy people. Therefore, biomarkers that help us understand which individuals are at risk of being affected are needed. A research team led from Lund University in Sweden, followed 752 people who, when the study started, were newly diagnosed with type 2 diabetes. ...

UVA harnesses AI to improve brain cancer care

2025-08-07

University of Virginia School of Medicine scientists are tapping the power of artificial intelligence to enhance and accelerate treatment for glioblastoma, the deadliest brain cancer. UVA researcher Bijoy Kundu, PhD, and colleagues are developing an AI imaging approach to distinguish between tumor progression and brain changes caused by tumor treatment. It now can take months to make that distinction, leaving doctors uncertain if the tumor is growing and stalling important care decisions. Kundu’s AI approach is already outperforming ...

MIT imaging tech promises deepest looks yet into living brain tissue at single-cell resolution

2025-08-07

Both for research and medical purposes, researchers have spent decades pushing the limits of microscopy to produce ever deeper and sharper images of brain activity, not only in the cortex but also in regions underneath such as the hippocampus. In a new study, a team of MIT scientists and engineers demonstrates a new microscope system capable of peering exceptionally deep into brain tissues to detect the molecular activity of individual cells by using sound. “The major advance here is to enable us to image deeper at single-cell resolution,” ...

City of Hope Research Spotlight, July 2025

2025-08-07

LOS ANGELES — City of Hope® Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, life-threatening diseases. Each spotlight features research-related news, such as recognitions, collaborations and the latest research defining the future of medical treatment. This roundup highlights two innovative clinical trials for promising cancer treatments, a potential liquid biopsy for gastric cancer, new insights into how to boost immune system ...

New experiment paves the way for secure, high-speed communication

2025-08-07

In a new paper published in Light: Science & Applications, a team of scientists from the Technical University of Denmark (DTU), the Austrian Institute of Technology (AIT), Fragmentix, University of Waterloo (UW), and Technische Universität Wien (TU) have successfully demonstrated a more practical and robust method for quantum key distribution, a breakthrough that could soon lead to more secure and cost-effective communication networks worldwide. Imagine sharing secrets today that will stay safe – even from the most powerful quantum computers of tomorrow. That’s the promise of quantum key distribution (QKD), a method that uses the principles ...

Maple compound offers new way to fight tooth decay

2025-08-07

Washington, D.C. — A new study in the journal Microbiology Spectrum highlights the potential of using a natural compound from maple to combat the bacteria responsible for tooth decay: Streptococcus mutans. The compound, epicatechin gallate, is a powerful and safe alternative to traditional plaque-fighting agents. Its natural abundance, affordability and lack of toxicity make it especially promising for inclusion in oral care products such as mouthwashes, offering a safer option for young children, who often accidentally swallow mouthwash. The new study emerged as an offshoot of research into natural compounds that ...

Novel immunologic surveillance study provides new insights into post-pandemic return of respiratory viruses

2025-08-07

AURORA, Colo. (Aug. 7, 2025) – The first paper from a multi-year clinical research study has been published in The Lancet Infectious Diseases: Dynamics of Endemic Virus Re-emergence in Children in the USA Following the COVID-19 Pandemic (2022-2023): A Longitudinal Immunoepidemiologic Surveillance Study and demonstrates how the approach can improve modeling to better predict future outbreaks. The paper shares findings from a multicenter clinical research study, one of many studies that are part of the recently launched PREMISE (Pandemic Response Repository through Microbial and Immune Surveillance ...

Cost-effectiveness of 2023-2024 COVID-19 vaccination in US adults

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: